EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis

NCT02234843 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Standard of Care

Sponsor

Bayer

Collaborators

[object Object]